Baxter's North Carolina Facility Manufactures ~60% Of IV Fluids And Peritoneal Dialysis Solutions, Senator Demands Immediate Action To Protect Patient Care Amid Shortage
Baxter's North Carolina Facility Manufactures ~60% Of IV Fluids And Peritoneal Dialysis Solutions, Senator Demands Immediate Action To Protect Patient Care Amid Shortage
The Baxter facility is responsible for manufacturing approximately 60% of IV fluids and peritoneal dialysis solutions available to health care providers in the U.S.U.S. Senator Amy Klobuchar (D-MN) is calling on U.S. Department of Health and Human Services (HHS) Secretary Xavier Becerra to utilize all available resources to tackle the national shortage of intravenous (IV) solutions.
明尼蘇達州參議員艾米·克洛布徹（D-MN）呼籲美國衛生及公衆服務部長哈維爾·貝塞拉利用所有可用資源解決國家靜脈輸液（IV）溶液的短缺問題。
This crisis follows the shutdown of Baxter International's (NYSE:BAX) largest IV solutions manufacturing facility due to flooding from Hurricane Helene.
這一危機是由於颶風海倫（Hurricane Helene）引發的，導致巴克斯特國際（NYSE:BAX）最大的靜脈輸液製造設施關閉。
With Hurricane Milton looming, Senator Klobuchar warns that another facility in Daytona Beach, Florida, may also be at risk, worsening the current situation.
隨着颶風米爾頓逐漸逼近，克洛布徹參議員警告稱，佛羅里達州戴通納比奇的另一家設施也可能面臨風險，惡化當前情況。
The Baxter facility is responsible for manufacturing approximately 60% of IV fluids and peritoneal dialysis solutions available to health care providers in the U.S.
巴克斯特設施負責製造美國醫療保健提供者使用的約60%的靜脈輸液和腹膜透析溶液。
Senator Klobuchar expressed deep concern over the implications of this shortage on patient care.
克洛布徹參議員對這一短缺對患者護理的影響深表關切。
"Flooding from Hurricane Helene compromised the safe operations, inventory, raw materials and roadway access at Baxter International's intravenous (IV) solution plant in Marion, North Carolina," wrote Senator Klobuchar.
「海倫颶風引發的洪水影響了巴克斯特國際位於北卡羅來納州馬里昂的靜脈輸液工廠的安全運營、庫存、原材料和道路通達情況，」克洛布徹參議員寫道。
"As a result of Hurricane Helene, hospitals, dialysis centers, and other health care providers around the country—including many in Minnesota—are already being forced to ration these basic, but life-saving supplies."
「由於海倫颶風，全國各地的醫院、透析中心以及其他醫療保健提供者，包括許多明尼蘇達州的機構，已被迫對這些基本但卻救命的物資進行配給，」克洛布徹參議員表示。
To mitigate the impact of this critical shortage, Klobuchar urged the HHS to act swiftly, coordinating with the Federal Trade Commission and the Department of Justice to prevent the distribution of counterfeit IV solutions.
爲緩解這一嚴重短缺的影響，克洛布徹敦促美國衛生及公衆服務部與美國聯邦貿易委員會以及司法部緊急合作，防止僞劣靜脈輸液的流通。
She called for measures to safeguard against price gouging and other illegal practices by companies marketing FDA-approved IV solutions.
她要求採取措施，防範公司在市場推廣FDA批准的靜脈注射溶液時的哄擡價格和其他非法行爲。
Klobuchar stressed that no single entity should dominate the supply of such vital medical resources, as this poses a significant risk to national health and safety.
Klobuchar強調，不應讓任何單一實體主導這些重要醫療資源的供應，因爲這對國家的健康和安全構成重大風險。
The senator's efforts to combat drug shortages are not new.
參議員爲應對藥物短缺所做的努力並非新鮮事。
The German healthcare group Fresenius SE (OTC:FSNUF) announced that its generic hospital drugs division, Fresenius Kabi, has recently commenced the production of intravenous (IV) solutions at a new facility in Wilson, North Carolina.
德國醫療保健集團Fresenius SE（場外交易：FSNUF）宣佈，其下屬醫院藥品部門Fresenius Kabi最近在北卡羅來納州威爾遜的一家新工廠開始生產靜脈（IV）溶液。
Additionally, Reuters highlighted the company is exploring options to expedite the launch of additional production lines at this unaffected site.
此外，路透社指出，該公司正在探索選項，以加快在這個未受影響的地點啓動額外生產線的進程。
Fresenius said increasing U.S. production at the Wilson facility will take several months, but it won't be sufficient to offset a prolonged shutdown at Baxter.
Fresenius表示，在威爾遜工廠增加美國生產將需要幾個月時間，但這並不足以彌補Baxter公司長期關閉的影響。
Price Action: BAX stock is up 2% at $37.87 at last check Wednesday.
股價走勢：BAX股票在週三最後一次檢查時上漲2%，報37.87美元。
- Honeywell Expands Qualcomm Partnership: AI And Connectivity To Supercharge Energy Industry Operations.
- 霍尼韋爾擴大高通合作：人工智能和連接性將加強能源行業運營。
